Pierre Theurey, Jennifer Rieusset  Trends in Endocrinology & Metabolism 

Slides:



Advertisements
Similar presentations
Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Improving Glucose Metabolism With Resveratrol in.
Advertisements

Figure 3 Metabolism in homeostatic chondrocytes
Volume 142, Issue 6, Pages (May 2012)
AMPK-Dependent Phosphorylation of ULK1 Induces Autophagy
Figure 1 mTOR pathway activation
Fatty Acid Metabolism Meets Organelle Dynamics
Nat. Rev. Nephrol. doi: /nrneph
Figure 4 Altered metabolism in chondrocytes in osteoarthritis
Figure 1 Control of hepatic gluconeogenesis
Nat. Rev. Endocrinol. doi: /nrendo
Figure 3 Physiological regulation of autophagy in the heart
Figure 1 mTOR complex biology
The pathway signalling starts with the binding of insulin or growth factors to insulin receptors. The pathway signalling starts with the binding of insulin.
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Maria M. Mihaylova, David M. Sabatini, Ömer H. Yilmaz  Cell Stem Cell 
Is REDD1 a Metabolic Éminence Grise?
Coming up for air: HIF-1 and mitochondrial oxygen consumption
Metformin—Acting through Cyclic AMP as well as AMP?
Metformin: From Mechanisms of Action to Therapies
Ketone bodies as signaling metabolites
Figure 1 The insulin signalling pathway
Angelika S. Rambold, Erika L. Pearce  Trends in Immunology 
Rapamycin: One Drug, Many Effects
Metabolic Regulation of the Immune Humoral Response
FGFR Signaling as a Target for Lung Cancer Therapy
Cristoforo Silvestri, Vincenzo Di Marzo  Cell Metabolism 
Autophagy in kidney disease and aging: lessons from rodent models
An Emerging Role of mTOR in Lipid Biosynthesis
Metabolic Control of Autophagy
mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
Glucose Restriction: Longevity SIRTainly, but without Building Muscle?
Mitochondria: In Sickness and in Health
Live Longer sans the AT1A Receptor
Silencing Insulin Resistance through SIRT1
Estrogen Receptors and the Metabolic Network
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
AKT/PKB Signaling: Navigating the Network
Conserved Metabolic Regulatory Functions of Sirtuins
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
Volume 93, Issue 5, Pages (March 2017)
AKT/PKB Signaling: Navigating Downstream
Varman T. Samuel, Gerald I. Shulman  Cell Metabolism 
Ophélie Meynet, Jean-Ehrland Ricci  Trends in Molecular Medicine 
Rapamycin: One Drug, Many Effects
Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis  Kosaku Uyeda,
Organelle crosstalk in the kidney
Metabolic Homeostasis: HDACs Take Center Stage
Toshimasa Yamauchi, Takashi Kadowaki  Cell Metabolism 
Volume 11, Issue 5, Pages (November 2012)
Evolution of Mitochondria as Signaling Organelles
Volume 3, Issue 1, Pages 9-13 (January 2006)
Metabolic Regulation by p53 Family Members
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis  Kosaku Uyeda,
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Sestrins Orchestrate Cellular Metabolism to Attenuate Aging
Tobias B. Huber, Gerd Walz, E Wolfgang Kuehn  Kidney International 
The Salt-Inducible Kinases: Emerging Metabolic Regulators
Collecting new targets in MODY
Transcriptional Coregulators: Fine-Tuning Metabolism
Calcium Signaling: Pyruvate and CRAC Meet at the Crossroads
Dysregulation of the mTOR Pathway Secondary to Mutations or a Hostile Microenvironment Contributes to Cancer and Poor Wound Healing  Richard A.F. Clark,
Metformin: From Mechanisms of Action to Therapies
Lesley-Ann Martin, Mitch Dowsett  Cancer Cell 
Mitochondrial Dynamics: A Strategy for Avoiding Autophagy
C16:0-Ceramide Signals Insulin Resistance
Autophagy and the Integrated Stress Response
Figure 1 Thyroid hormone effects on hepatic lipid metabolism
Nutrient Sensing, Metabolism, and Cell Growth Control
DisSIRTing on LXR and Cholesterol Metabolism
Presentation transcript:

Mitochondria-Associated Membranes Response to Nutrient Availability and Role in Metabolic Diseases  Pierre Theurey, Jennifer Rieusset  Trends in Endocrinology & Metabolism  Volume 28, Issue 1, Pages 32-45 (January 2017) DOI: 10.1016/j.tem.2016.09.002 Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 1 Adaptations of Mitochondrial Dynamics and Function to Nutrient Scarcity. During caloric restriction or fasting, increase in cAMP activates protein kinase A (PKA), which phosphorylates and inactivates dynamin-related protein 1 (Drp1), thereby promoting mitochondrial elongation. Nutrient deprivation also increases NAD+ levels, leading to the activation of the mitochondrial sirtuin deacetylase SIRT3 and to deacetylation of key mitochondrial proteins. Lastly, the increase in the AMP-to-ATP ratio activates AMP-activated protein kinase (AMPK), which phosphorylates both Drp1 and mitochondrial fission factor (Mff), thus promoting both antifission and profission signals, respectively. AMPK regulates SIRT1 activity impacting protein acetylation. AMPK also controls the phosphorylation of key transcription (co)activators such as peroxisomal proliferator-activated receptor-gamma coactivator 1-alpha (PGC1α) and fork-head box O (FOXO), thus regulating mitochondrial gene expression. Both PGC1α and FOXO are also targets of SIRT1-dependent deacetylation. Lastly, AMPK regulates mitophagy via direct phosphorylation of Unc-51-like autophagy activating kinase 1 (ULK1) and inhibition of mammalian target of rapamycin complex 1 (mTORC1) suppression of ULK1. Altogether, these acute and long-term regulations allow mitochondria to adapt their function to nutrient availability. Trends in Endocrinology & Metabolism 2017 28, 32-45DOI: (10.1016/j.tem.2016.09.002) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 2 Key Figure: Regulation of Endoplasmic Reticulum (ER)–Mitochondria Interactions and Ca2+ Exchange by Cellular Energy Levels At mitochondria-associated membrane (MAM), Ca2+ transfer from the ER to mitochondria is mediated by the inositol-1,4,5-trisphosphate receptor (IP3R)–glucose-regulated protein 75 (Grp75)–voltage-dependent anion-selective channel (VDAC)–cyclophilin D (CypD) complex. Organelle interactions and Ca2+ transfer are controlled by cellular energy levels and impact mitochondria bioenergetics. Blue triangles on either side of the black line (in the broken boxes) illustrate the distance between ER and mitochondria. Left: Following fasting/nutrient deprivation, glucagon increases the phosphorylation of IP3R via the cAMP–protein kinase A (PKA) pathway, thus activating IP3R-mediated Ca2+ release. Both protein phosphatase 2A (PP2A) and phosphatase and tensin homolog (PTEN) participate in the regulation of Ca2+ release from the ER through IP3R, counteracting its Akt-mediated reduction. Fasting is also associated with an increase of ER–mitochondria interactions by an unknown mechanism. In this context, elongated mitochondria preferentially use free fatty acid (FFA) as metabolic substrate for oxidative phosphorylations (OXPHOSs). Right: In the fed state, insulin activates a signaling pathway leading to the phosphorylation and activation of Akt in two subcellular compartments: in cytoplasm near the plasma membrane and at the MAM interface. Mammalian target of rapamycin complex 2 (mTORC2) can phosphorylate and activate Akt in these two localizations. Activated Akt at MAM phosphorylates and inactivates IP3R, leading to reduced IP3R-mediated Ca2+ export from the ER. After a meal, ER–mitochondria interactions are reduced, presumably by a glucose signal. High glucose levels activate the pentose phosphate–PP2A pathway, reducing ER–mitochondria interactions and Ca2+ transfer through an unknown mechanism. This regulation may require PP2A removal from MAM in order to favor phosphorylated Akt. In this context, fragmented mitochondria preferentially use glucose metabolites as substrate for OXPHOS. CoA, coenzyme A; IRS1/2: insulin receptor substrate 1/2; PDK1: phosphoinositide-dependent kinase 1; PI3K, phosphoinositide 3-kinase. Trends in Endocrinology & Metabolism 2017 28, 32-45DOI: (10.1016/j.tem.2016.09.002) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 3 Proposed Model for the Regulation of Metabolic Flexibility by Endoplasmic Reticulum (ER)–Mitochondria Interactions. Fasted to postprandial transition, as well as increase in glucose levels, reduces ER–mitochondria interactions through the activation of the pentose phosphate–protein phosphatase 2A (PP–PP2A) pathway, in turn inducing mitochondria fission and reducing respiration in hepatocytes. The regulation of mitochondria-associated membrane integrity and function by glucose levels should control metabolic flexibility by slowing down mitochondrial lipid oxidation (beta-oxidation) and favoring lipogenesis from excess carbohydrates, as illustrated in the broken box at the bottom of the figure. CoA, coenzyme A; OXPHOS, oxidative phosphorylation; TCA, tricarboxylic acid. Trends in Endocrinology & Metabolism 2017 28, 32-45DOI: (10.1016/j.tem.2016.09.002) Copyright © 2016 Elsevier Ltd Terms and Conditions